Journal
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
Volume 1823, Issue 10, Pages 1658-1665Publisher
ELSEVIER
DOI: 10.1016/j.bbamcr.2012.06.011
Keywords
Sphingolipid; Cytokine; Adenylate cyclase; CREB; p38 MAPK; DUSP-1
Categories
Funding
- Senglet Stiftung - Switzerland
- Endeavour Postgraduate Award - Australia
- National Health and Medical Research Council of Australia [570856]
- University of Sydney Thompson Fellowship
Ask authors/readers for more resources
Sphingosine 1-phosphate (S1P), a bioactive sphingolipid elevated in asthmatic airways, is increasingly recognized as playing an important role in respiratory disease. S1P activates receptor-mediated signaling to modulate diverse cellular functions and promote airway inflammation. Although many of the stimulatory pathways activated by SIP have been delineated, especially mitogen-activated protein kinases (MAPK), the question of whether SIP exerts negative feedback control on its own signaling cascade via upregulation of phosphatases remains unexplored. We show that SIP rapidly and robustly upregulates mRNA and protein expression of the MAPK deactivator-MAPK phosphatase 1 (MKP-1). Utilizing the pivotal airway structural cell, airway smooth muscle (ASM), we confirm that S1P activates all members of the MAPK family and, in part, SIP upregulates MKP-1 expression in a p38 MAPK-dependent manner. MKP-1 is a CAMP response element binding (CREB) protein-responsive gene and here, we reveal for the first time that an adenylate cyclase/PKA/CREB-mediated pathway also contributes to S1P-induced MKP-1. Thus, by increasing MKP-1 expression via parallel p38 MAPK- and CREB-mediated pathways, SIP temporally regulates MAPK signaling pathways by upregulating the negative feedback controller MKP-1. This limits the extent and duration of pro-inflammatory MAPK signaling and represses cytokine secretion in ASM cells. Taken together, our results demonstrate that SIP stimulates both kinases and the phosphatase MKP-1 to control inflammation in ASM cells and may provide a greater understanding of the molecular mechanisms responsible for the pro-asthmatic functions induced by the potent bioactive sphingolipid SIP in the lung. (c) 2012 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available